The Aryl hydrocarbon Receptor (AhR) is a mediator of xenobiotic toxicity, best recognized for conveying the deleterious human health effects following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin) and related environmental contaminants. Mechanistically, the AhR is known to function as a ligand-activated transcription factor that binds to a canonical xenobiotic response element (XRE) in association with its heterodimerization partner, the AhR nuclear translocator (Arnt) protein. However, within the repertoire of AhR target genes identified in recent years, many lack a clearly defined XRE, highlighting the growing realization that AhR-mediated gene expression appears to involve additional mechanisms distinct from the well- characterized process involving the XRE. We recently identified a non-consensus XRE (NC-XRE) that recruits a novel AhR-containing protein-DNA complex. DNA binding and functional studies confirmed that NC-XRE binding by the AhR is independent of the Arnt protein, and instead occurs in partnership with the Kruppel-like factor 6 (KLF6) tumor suppressor. Mass spectrometry-based proteomics identified Carbamoyl-Phosphate Synthase 1 (CPS1) as an additional component of the TCDD induced AhR-KLF6 NC-XRE-bound complex. Preliminary evidence indicates that TCDD treatment promotes reversible site-specific homocitrullination (carbamoylation of lysine residues) of lysine 34 on histone H1, supporting the hypothesis that CPS1 recruitment to the NC-XRE complex catalyzes a hitherto unknown epigenetic modification responsible for chromatin remodeling and transcriptional regulation. Our evidence also reveals that AhR-dependent transcriptional activation of the peptidylarginine deiminase type-2 (PADI2) gene requires CPS1 recruitment. Since the PADI2 protein modifies arginine 26 on histone H3 to facilitate transcriptional activation, the data are consistent with the AhR catalyzing a distinct epigenetic signature through the direct and indirect action of specific chromatin modifying enzymes. In keeping with our long-term objective to understand the pathophysiology of AhR activity, this proposal will examine three specific aims designed to characterize the epigenetic modifications initiated by the recruitment of CPS1 to chromatin.
Specific aim 1 describes a detailed characterization of the CPS1 interaction with the novel AhR-KLF6 complex.
Specific Aim 2 will test the hypothesis that AhR-mediated recruitment of CPS1 introduces epigenetic modifications that alter chromatin into an open, transcriptionally permissive conformation.
Specific Aim 3 will use ChIP-sequencing and whole transcriptome shotgun sequencing to provide a global genomic assessment of the functional CPS1-dependent AhR-KLF6 binding sites. Identification of this novel AhR complex represents a paradigm shift in our understanding of AhR biology, with discovery of the homocitrulline post-translational modification embodying a significant and innovative insight into epigenetic transcriptional control.

Public Health Relevance

Exposure to dioxin and related ubiquitous environmental pollutants comprises a persistent human health risk to the general population. Comprehending how these pollutants alter the normal biological events that trigger the deleterious toxic outcomes including cancer and immune dysfunction, requires a detailed understanding of the molecular processes. This application proposes studies examining a novel genomic signaling process affecting gene expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES026874-05
Application #
9948488
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Tyson, Frederick L
Project Start
2016-06-01
Project End
2021-05-31
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Texas Med Br Galveston
Department
Pharmacology
Type
Schools of Medicine
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
Joshi, Aditya D; Hossain, Ekram; Elferink, Cornelis J (2017) Epigenetic Regulation by Agonist-Specific Aryl Hydrocarbon Receptor Recruitment of Metastasis-Associated Protein 2 Selectively Induces Stanniocalcin 2 Expression. Mol Pharmacol 92:366-374
Croisant, Sharon A; Lin, Yu-Li; Shearer, Joseph J et al. (2017) The Gulf Coast Health Alliance: Health Risks Related to the Macondo Spill (GC-HARMS) Study: Self-Reported Health Effects. Int J Environ Res Public Health 14:
Gaziova, Ivana; Jackson, Daniel; Boor, Paul J et al. (2016) The MET Receptor Tyrosine Kinase Confers Repair of Murine Pancreatic Acinar Cells following Acute and Chronic Injury. PLoS One 11:e0165485
Joshi, Aditya D; Mustafa, Mehnaz G; Lichti, Cheryl F et al. (2015) Homocitrullination Is a Novel Histone H1 Epigenetic Mark Dependent on Aryl Hydrocarbon Receptor Recruitment of Carbamoyl Phosphate Synthase 1. J Biol Chem 290:27767-78
Mustafa, Gul M; Larry, Denner; Petersen, John R et al. (2015) Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients. World J Hepatol 7:1312-24
Jackson, D P; Joshi, A D; Elferink, C J (2015) Ah Receptor Pathway Intricacies; Signaling Through Diverse Protein Partners and DNA-Motifs. Toxicol Res (Camb) 4:1143-1158
Kotarba, Joseph A; Croisant, Sharon A; Elferink, Cornelis et al. (2014) COLLABORATING WITH THE COMMUNITY: THE EXTRA-TERRITORIAL TRANSLATIONAL RESEARCH TEAM. J Transl Med Epidemiol 2:1038
Dietrich, Cornelia; Kaina, Bernd (2010) The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth. Carcinogenesis 31:1319-28